{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:30:27Z","timestamp":1790353827790,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018895","name":"National Institute of Technology, Raipur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007488","name":"Indian Institute of Technology Delhi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011067","name":"Indian Institute of Technology Mandi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011067","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Pathogenesis and Therapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.cpt.2025.02.005","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T18:26:38Z","timestamp":1740248798000},"page":"473-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Repurposing antibiotics: A dual-action approach against bacteria-induced cancer"],"prefix":"10.1016","volume":"3","author":[{"given":"Aditya","family":"Upadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hem","family":"Chandra Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharm","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8735-479X","authenticated-orcid":false,"given":"Awanish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpt.2025.02.005_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11655-021-3512-5","article-title":"Frequently used allopathic and traditional medicine for COVID-19 treatment and feasibility of their integration","volume":"28","author":"Upadhayay","year":"2022","journal-title":"Chin J Integr Med"},{"key":"10.1016\/j.cpt.2025.02.005_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122418","article-title":"Interrogating Salmonella typhi biofilm formation and dynamics to understand antimicrobial resistance","volume":"339","author":"Upadhyay","year":"2024","journal-title":"Life Sci"},{"key":"10.1016\/j.cpt.2025.02.005_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2023.116082","article-title":"microRNA as biomarkers in tuberculosis: a new emerging molecular diagnostic solution","volume":"108","author":"Agrawal","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cpt.2025.02.005_bib4","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cpt.2025.02.005_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.adcanc.2022.100032","article-title":"Salmonella typhi induced oncogenesis in gallbladder cancer: Co-relation and progression","volume":"4","author":"Upadhayay","year":"2022","journal-title":"Adv Cancer Biol Metastasis"},{"key":"10.1016\/j.cpt.2025.02.005_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105966","article-title":"Substantial relation between the bacterial biofilm and oncogenesis progression in host","volume":"175","author":"Upadhyay","year":"2023","journal-title":"Microb Pathog"},{"key":"10.1016\/j.cpt.2025.02.005_bib7","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.32604\/biocell.2022.018845","article-title":"Biomonitoring of endosulfan toxicity in human","volume":"46","author":"Karn","year":"2022","journal-title":"Biocell"},{"key":"10.1016\/j.cpt.2025.02.005_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/10408410601023557","article-title":"The contribution of cytolethal distending toxin to bacterial pathogenesis","volume":"32","author":"Smith","year":"2006","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.cpt.2025.02.005_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.32007\/jfacmedbagdad.5111171","article-title":"Isolation and identification of bacteria associated with bladder cancer patients","volume":"51","author":"Al-Dabbagh","year":"2009","journal-title":"J Fac Med Baghdad"},{"key":"10.1016\/j.cpt.2025.02.005_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.procbio.2023.02.022","article-title":"Combinatorial enzyme therapy: a promising neoteric approach for bacterial biofilm disruption","volume":"129","author":"Upadhyay","year":"2023","journal-title":"Process Biochem"},{"key":"10.1016\/j.cpt.2025.02.005_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/1389202924666230815144126","article-title":"Deciphering target protein cascade in Salmonella typhi biofilm using genomic data mining, and protein-protein interaction","volume":"24","author":"Upadhyay","year":"2023","journal-title":"Curr Genom"},{"key":"10.1016\/j.cpt.2025.02.005_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/14728222.2024.2344699","article-title":"Molecular drilling to combat salmonella typhi biofilm using L-asparaginase via multiple targeting process","volume":"28","author":"Upadhyay","year":"2024","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.cpt.2025.02.005_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100890","article-title":"Resistance-proof antimicrobial drug discovery to combat global antimicrobial resistance threat","volume":"66","author":"Upadhayay","year":"2023","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.cpt.2025.02.005_bib14","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","article-title":"Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer","volume":"611","author":"Galeano","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cpt.2025.02.005_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44264-7","article-title":"Drug repurposing: a nexus of innovation, science, and potential","volume":"13","author":"De Rosa","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.cpt.2025.02.005_bib16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41568-023-00594-2","article-title":"Bacteria in cancer initiation, promotion and progression","volume":"23","author":"El","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cpt.2025.02.005_bib17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41392-020-00324-2","article-title":"Overview of current targeted therapy in gallbladder cancer","volume":"5","author":"Song","year":"2020","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.cpt.2025.02.005_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.106979","article-title":"Cellulase exhibited a therapeutic potential to inhibit Salmonella enterica serovar Typhi biofilm by targeting multiple regulatory proteins of biofilm","volume":"196","author":"Upadhyay","year":"2024","journal-title":"Microb Pathog"},{"key":"10.1016\/j.cpt.2025.02.005_bib19","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3390\/ijms18091887","article-title":"Biofilm producing Salmonella typhi: chronic colonization and development of gallbladder cancer","volume":"18","author":"Di Domenico","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpt.2025.02.005_bib20","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.3390\/ijms24032895","article-title":"Helicobacter pylori and gastric cancer: pathogenetic mechanisms","volume":"24","author":"Salvatori","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpt.2025.02.005_bib21","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1056\/NEJMcp1710945","article-title":"Helicobacter pylori infection","volume":"380","author":"Crowe","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpt.2025.02.005_bib22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.micro.54.1.615","article-title":"The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer","volume":"54","author":"Ernst","year":"2000","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.cpt.2025.02.005_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12029-020-00518-5","article-title":"Molecular mechanism of Helicobacter pylori-induced gastric cancer","volume":"52","author":"Alipour","year":"2021","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.cpt.2025.02.005_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/23744235.2019.1588472","article-title":"Helicobacter pylori: molecular basis for colonization and survival in gastric environment and resistance to antibiotics. A short review","volume":"51","author":"Fagoonee","year":"2019","journal-title":"Inf Disp"},{"key":"10.1016\/j.cpt.2025.02.005_bib25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.chom.2014.02.008","article-title":"Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis","volume":"15","author":"Hatakeyama","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cpt.2025.02.005_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.micpath.2018.02.016","article-title":"Influence of Helicobacter pylori virulence factors CagA and VacA on pathogenesis of gastrointestinal disorders","volume":"117","author":"Nejati","year":"2018","journal-title":"Microb Pathog"},{"key":"10.1016\/j.cpt.2025.02.005_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fmicb.2010.00115","article-title":"A tale of two toxins: Helicobacter pylori CagA and VacA modulate host pathways that impact disease","volume":"1","author":"Jones","year":"2010","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cpt.2025.02.005_bib28","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cpt.2025.02.005_bib29","article-title":"Characteristics of gut microbiota in patients with clear cell renal cell carcinoma","volume":"13","author":"Chen","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cpt.2025.02.005_bib30","article-title":"Alteration of pro-carcinogenic gut microbiota is associated with clear cell renal cell carcinoma tumorigenesis","volume":"14","author":"Yang","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cpt.2025.02.005_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s13402-023-00876-9","article-title":"The microbiota and renal cell carcinoma","volume":"47","author":"Wu","year":"2024","journal-title":"Cell Oncol"},{"key":"10.1016\/j.cpt.2025.02.005_bib32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","article-title":"Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin","volume":"14","author":"Rubinstein","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cpt.2025.02.005_bib33","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","article-title":"Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.cpt.2025.02.005_bib34","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s00467-016-3527-x","article-title":"The gut-kidney axis","volume":"32","author":"Evenepoel","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.cpt.2025.02.005_bib35","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cpt.2025.02.005_bib36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/medicina57080749","article-title":"Bladder cancer: current challenges and future directions","volume":"57","author":"Dobruch","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.cpt.2025.02.005_bib37","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/JCM.02876-13","article-title":"Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder","volume":"52","author":"Hilt","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cpt.2025.02.005_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29054-w","article-title":"The urinary microbiome associated with bladder cancer","volume":"8","author":"Bu\u010devi\u0107 Popovi\u0107","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.cpt.2025.02.005_bib39","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4111\/icu.2020.61.4.338","article-title":"The microbiome in urological diseases","volume":"61","author":"Lee","year":"2020","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.cpt.2025.02.005_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004901","article-title":"Inflammation-induced cell proliferation potentiates DNA damage-induced mutations in vivo","volume":"11","author":"Kiraly","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.cpt.2025.02.005_bib41","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1128\/IAI.69.11.6839-6845.2001","article-title":"Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2 gene","volume":"69","author":"Thomas","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.cpt.2025.02.005_bib42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cpt.2025.02.005_bib43","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.coph.2017.08.009","article-title":"Drug discovery for the treatment of substance use disorders: novel targets, repurposing, and the need for new paradigms","volume":"35","author":"Chiamulera","year":"2017","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.cpt.2025.02.005_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2019.103937","article-title":"Evolution of rifampicin treatment for tuberculosis","volume":"74","author":"Grobbelaar","year":"2019","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.cpt.2025.02.005_bib45","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00280-023-04617-5","article-title":"Azithromycin in cancer treatment: envisioning the probable link of mitochondrial dysfunction and necroptosis","volume":"93","author":"Hassan","year":"2024","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.cpt.2025.02.005_bib46","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.3390\/cancers13133193","article-title":"Repurposing of antimicrobial agents for cancer therapy: what do we know?","volume":"13","author":"Pfab","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.cpt.2025.02.005_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174593","article-title":"A brief look at antitumor effects of doxycycline in the treatment of colorectal cancer and combination therapies","volume":"916","author":"Ghasemi","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cpt.2025.02.005_bib48","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3390\/ijms23020831","article-title":"The anticancer potential of doxycycline and minocycline\u2014a comparative study on amelanotic melanoma cell lines","volume":"23","author":"Rok","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpt.2025.02.005_bib49","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/15384101.2016.1241929","article-title":"Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer","volume":"16","author":"Zhang","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cpt.2025.02.005_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151539","article-title":"Doxycycline promotes carcinogenesis & metastasis via chronic inflammatory pathway: an in vivo approach","volume":"11","author":"Nanda","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cpt.2025.02.005_bib51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.lab.2003.12.012","article-title":"Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells","volume":"143","author":"Onoda","year":"2004","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.cpt.2025.02.005_bib52","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/35036374","article-title":"Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis","volume":"2","author":"Bergers","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.cpt.2025.02.005_bib53","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s11274-013-1252-1","article-title":"Doxycycline interferes with quorum sensing-mediated virulence factors and biofilm formation in gram-negative bacteria","volume":"29","author":"Husain","year":"2013","journal-title":"World J Microbiol Biotechnol"},{"key":"10.1016\/j.cpt.2025.02.005_bib54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s40268-016-0133-0","article-title":"Pharmacokinetic interaction of rifampicin with oral versus intravenous anticancer drugs: challenges, dilemmas and paradoxical effects due to multiple mechanisms","volume":"16","author":"Srinivas","year":"2016","journal-title":"Drugs R&D"},{"key":"10.1016\/j.cpt.2025.02.005_bib55","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1158\/0008-5472.CAN-08-3417","article-title":"Rifampicin as an oral angiogenesis inhibitor targeting hepatic cancers","volume":"69","author":"Shichiri","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.cpt.2025.02.005_bib56","article-title":"Synthesis, characterization, and antitumor activity of a new iron-rifampicin complex: a novel prospective antitumor drug","volume":"57","author":"Saad","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.cpt.2025.02.005_bib57","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.livres.2023.11.005","article-title":"Synergistic impacts of rifampicin and doxorubicin against thioacetamide-induced hepatocellular carcinoma in rats","volume":"7","author":"Elshahawy","year":"2023","journal-title":"Liver Res"},{"key":"10.1016\/j.cpt.2025.02.005_bib58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4161\/cc.9.1.10354","article-title":"Inhibition of cancer progression by rifampicin: involvement of antiangiogenic and anti-tumor effects","volume":"9","author":"Shichiri","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cpt.2025.02.005_bib59","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.3390\/ijms23137383","article-title":"Low-dose rifabutin increases cytotoxicity in antimitotic-drug-treated resistant cancer cells by exhibiting strong P-gp-inhibitory activity","volume":"23","author":"Lee","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpt.2025.02.005_bib60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/pathogens10010015","article-title":"Rifabutin for the treatment of Helicobacter pylori infection: a review","volume":"10","author":"Gisbert","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.cpt.2025.02.005_bib61","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbrc.2016.02.120","article-title":"Antibiotic drug rifabutin is effective against lung cancer cells by targeting the eIF4E-\u03b2-catenin axis","volume":"472","author":"Li","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cpt.2025.02.005_bib62","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00003495-199244010-00009","article-title":"Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential","volume":"44","author":"Peters","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.cpt.2025.02.005_bib63","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000239580","article-title":"Significant survival benefit to patients with advanced non-small-cell lung cancer from treatment with clarithromycin","volume":"43","author":"Mikasa","year":"1997","journal-title":"Chemotherapy"},{"key":"10.1016\/j.cpt.2025.02.005_bib64","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/cancers17010059","article-title":"Synergistic potential of antibiotics with cancer treatments","volume":"17","author":"Nardo","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.cpt.2025.02.005_bib65","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3332\/ecancer.2020.1088","article-title":"Possible mechanisms of action of clarithromycin and its clinical application as a repurposing drug for treating multiple myeloma","volume":"14","author":"Takemori","year":"2020","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.cpt.2025.02.005_bib66","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41419-020-2349-8","article-title":"Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K","volume":"11","author":"Petroni","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.cpt.2025.02.005_bib67","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.advms.2020.03.002","article-title":"Clarithromycin effectively enhances doxorubicin-induced cytotoxicity and apoptosis in MCF7 cells through dysregulation of autophagy","volume":"65","author":"Amani","year":"2020","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.cpt.2025.02.005_bib68","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3390\/cancers4041318","article-title":"Azithromycin synergistically enhances anti-proliferative activity of vincristine in cervical and gastric cancer cells","volume":"4","author":"Zhou","year":"2012","journal-title":"Cancers"},{"key":"10.1016\/j.cpt.2025.02.005_bib69","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.4238\/2014.April.14.8","article-title":"Azithromycin enhances the favorable results of paclitaxel and cisplatin in patients with advanced non-small cell lung cancer","volume":"13","author":"Chu","year":"2014","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.cpt.2025.02.005_bib70","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40880-018-0309-9","article-title":"Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4\/5 in colon cancer cells in vitro and in vivo","volume":"38","author":"Qiao","year":"2018","journal-title":"Cancer Commun"},{"key":"10.1016\/j.cpt.2025.02.005_bib71","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1038\/s41416-023-02210-4","article-title":"Azithromycin, a potent autophagy inhibitor for cancer therapy, perturbs cytoskeletal protein dynamics","volume":"128","author":"Takano","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cpt.2025.02.005_bib72","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s12325-020-01235-y","article-title":"Effectiveness and safety of high dose tigecycline for the treatment of severe infections: a systematic review and meta-analysis","volume":"37","author":"Zha","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.cpt.2025.02.005_bib73","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2147\/DDDT.S365512","article-title":"Population pharmacokinetics of tigecycline: a systematic review","volume":"16","author":"Zhou","year":"2022","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.cpt.2025.02.005_bib74","first-page":"3031","article-title":"Anti-tumor activity of tigecycline (in Chinese)","volume":"37","author":"Zhao","year":"2021","journal-title":"Chin J Biotechnol"},{"key":"10.1016\/j.cpt.2025.02.005_bib75","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cpt.2025.02.005_bib76","doi-asserted-by":"crossref","first-page":"8313","DOI":"10.1038\/s41598-023-35519-4","article-title":"Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EGFR-TKIs","volume":"13","author":"Tone","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.cpt.2025.02.005_bib77","first-page":"469","article-title":"The combined effects of celecoxib and minocycline hydrochloride on inhibiting the osseous metastasis of breast cancer in nude mice","volume":"23","author":"Niu","year":"2008","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.cpt.2025.02.005_bib78","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ygyno.2012.01.006","article-title":"Minocycline inhibits growth of epithelial ovarian cancer","volume":"125","author":"Pourgholami","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cpt.2025.02.005_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060817","article-title":"Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies","volume":"8","author":"Ataie-Kachoie","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cpt.2025.02.005_bib80","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/ijms20020268","article-title":"Ciprofloxacin enhances the chemosensitivity of cancer cells to ABCB1 substrates","volume":"20","author":"Gupta","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpt.2025.02.005_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111810","article-title":"Anticancer and antimicrobial effects of novel ciprofloxacin fatty acids conjugates","volume":"185","author":"Chrzanowska","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.cpt.2025.02.005_bib82","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.3390\/molecules29225382","article-title":"Unveiling the anticancer potential of a new ciprofloxacin-chalcone hybrid as an inhibitor of topoisomerases I & II and apoptotic inducer","volume":"29","author":"Ali","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.cpt.2025.02.005_bib83","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12885-021-09125-4","article-title":"Ceftazidime and cefepime antagonize 5-fluorouracil's effect in colon cancer cells","volume":"22","author":"Pfab","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cpt.2025.02.005_bib84","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3892\/ijmm.2015.2297","article-title":"Cefepime, a fourth-generation cephalosporin, in complex with manganese, inhibits proteasome activity and induces the apoptosis of human breast cancer cells","volume":"36","author":"Zhang","year":"2015","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.cpt.2025.02.005_bib85","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1007\/s00210-023-02839-1","article-title":"Minocycline as a prospective therapeutic agent for cancer and non-cancer diseases: a scoping review","volume":"397","author":"Rezaei","year":"2024","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.cpt.2025.02.005_bib86","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/d41573-021-00138-z","article-title":"Antibiotics switch to anticancer target","volume":"20","author":"Kingwell","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cpt.2025.02.005_bib87","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4627","article-title":"Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer","volume":"13","author":"Chrysostomou","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cpt.2025.02.005_bib88","article-title":"Role of integrin \u03b1v\u03b23 in doxycycline-induced anti-proliferation in breast cancer cells","volume":"10","author":"Chen","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.cpt.2025.02.005_bib89","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00900-21","article-title":"Enhanced antibacterial activity of repurposed mitomycin C and imipenem in combination with the lytic phage vB_KpnM-VAC13 against clinical isolates of Klebsiella pneumoniae","volume":"65","author":"Pacios","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cpt.2025.02.005_bib90","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000122590","article-title":"Mitomycin C in the treatment of gastrointestinal tumours: recent data and perspectives","volume":"31","author":"Hofheinz","year":"2008","journal-title":"Onkologie"},{"key":"10.1016\/j.cpt.2025.02.005_bib91","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/biology10060455","article-title":"Use of antibiotics and probiotics reduces the risk of metachronous gastric cancer after endoscopic resection","volume":"10","author":"Arai","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.cpt.2025.02.005_bib92","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/bies.20160","article-title":"The anthracycline antibiotics: antitumor drugs that alter chromatin structure","volume":"27","author":"Rabbani","year":"2005","journal-title":"Bioessays"},{"key":"10.1016\/j.cpt.2025.02.005_bib93","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1517\/17460441.1.6.549","article-title":"Anthracyclines as effective anticancer drugs","volume":"1","author":"Nadas","year":"2006","journal-title":"Expet Opin Drug Discov"}],"container-title":["Cancer Pathogenesis and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713225000254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713225000254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T11:30:51Z","timestamp":1761132651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949713225000254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":93,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2949713225000254"],"URL":"https:\/\/doi.org\/10.1016\/j.cpt.2025.02.005","relation":{},"ISSN":["2949-7132"],"issn-type":[{"value":"2949-7132","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing antibiotics: A dual-action approach against bacteria-induced cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Pathogenesis and Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpt.2025.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Medical Association (CMA).","name":"copyright","label":"Copyright"}]}}